Substance / Medication

Vilazodone

Overview

Active Ingredient
vilazodone
RxNorm CUI
1086769

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Vilazodone poisoning: a systematic review.
Baumgartner Kevin, Doering Michelle, Schwarz Evan · Clin Toxicol (Phila) · 2020
PMID: 31777303Meta-Analysis
Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis.
Zareifopoulos Nicholas, Dylja Irene · Asian J Psychiatr · 2017
PMID: 28483071Meta-Analysis
Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials.
Shi Ligen, Wang Jingyi, Xu Shenbin et al. · Drug Des Devel Ther · 2016
PMID: 27932864Meta-AnalysisFull text (PMC)
Double-blind switch study of vilazodone in the treatment of major depressive disorder.
Grant Jon E, Redden Sarah A, Leppink Eric W · Int Clin Psychopharmacol · 2017
PMID: 28177953RCT
A randomized controlled pilot trial of vilazodone for adult separation anxiety disorder.
Schneier Franklin R, Moskow Danielle M, Choo Tse-Hwei et al. · Depress Anxiety · 2017
PMID: 29071764RCT
Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study.
Eyre Harris, Siddarth Prabha, Cyr Natalie et al. · Pharmacopsychiatry · 2017
PMID: 28444658RCTFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Vilazodone (substance)
SNOMED CT
702837008
UMLS CUI
C1530072
RxNorm CUI
1086769

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.